BACE1 and Alzheimer disease: Additionally, during a longitudinal study, plasma BACE1 activity was higher in individuals with MCI that advanced to AD than those that did not advance (AD patients ≥2.6 mFU/min/μg and healthy control 2 to 6 mFU/min/μg) (Shen et al., 2018).